Aurobindo Pharma US FDA inspection at Telangana API facility concludes with 1 procedural observation
US FDA inspected Aurobindo Pharma's subsidiary Apitoria Pharma's API facility in Telangana, finding one procedural observation. Aurobindo will respond to the FDA.
\